Prevalence of PD‐L1 expression in head and neck squamous precancerous lesions: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Prevalence of PD‐L1 expression in head and neck squamous precancerous lesions: a systematic review and meta‐analysis

Published:2020-06-22 Issue:10 Volume:42 Page:3018-3030
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Girolami Ilaria¹,Pantanowitz Liron²,Munari Enrico³,Martini Maurizio⁴,Nocini Riccardo⁵,Bisi Nicola⁵,Molteni Gabriele⁵,Marchioni Daniele⁵,Ghimenton Claudio¹,Brunelli Matteo¹,Eccher Albino¹^ORCID

Affiliation:

1. Department of Pathology and Diagnostics University and Hospital Trust of Verona Verona Italy

2. Department of Pathology University of Pittsburgh Medical Center Pittsburgh Pennsylvania

3. Department of Pathology Sacro Cuore Don Calabria Hospital Italy

4. Division of Anatomic Pathology and Histology Catholic University‐Fondazione Policlinico Universitario “A. Gemelli” IRCCS Rome Italy

5. Department of Otorhinolaringology and Head & Neck Surgery University and Hospital Trust of Verona Verona Italy

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26339

Reference46 articles.

1. Oncology Meets Immunology: The Cancer-Immunity Cycle

2. PD-1 blockade induces responses by inhibiting adaptive immune resistance

3. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

4. Predictive biomarkers for checkpoint inhibitor-based immunotherapy

5. ORAL01.01: A Prospective, Multi-Institutional Assessment of Four Assays for PD-L1 Expression in NSCLC by Immunohistochemistry

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis;Current Cancer Drug Targets;2024-09

2. Comparative analysis of PDL1 and cluster of differentiation 68 marker expression in oral squamous cell carcinoma patients: Correlation with depth of invasion and immunofluorescence through immunohistochemistry;Dental Research Journal;2024-07

3. Oral Pre-malignancy: An Update on Novel Therapeutic Approaches;Current Oncology Reports;2024-06-12

4. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD‐L1‐induced malignant potential of oral squamous cell carcinoma;Journal of Oral Pathology & Medicine;2024-05

5. Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma;Head and Neck Pathology;2024-03-08